RECRUITING

Bridging the Evidence-to-practice Gap

Conditions

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The proposed project will address this evidence-to-practice gap by evaluating the effect of practice facilitation (PF) of the intervention implementation fidelity (primary outcome) and clinical measures at 12 months (secondary outcomes).

Official Title

Bridging the Evidence-to-practice Gap: Evaluating Practice Facilitation as a Strategy to Accelerate Translation of a Systems-level Adherence Intervention Into Safety Net Practices

Quick Facts

Study Start:2020-12-01

Study Completion:2027-11-30

Study Type:Not specified

Phase:Not Applicable

Enrollment:Not specified

Status:RECRUITING

Study ID

NCT03713515

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 90 Years

Sexes Eligible for Study:ALL

Accepts Healthy Volunteers:No

Standard Ages:ADULT, OLDER_ADULT

Inclusion Criteria	Exclusion Criteria
* Self-identify as Latino * Be fluent in English or Spanish * Be age 18 years or older * Receiving care in a safety-net primary care practice * Have uncontrolled HTN documented in the electronic health record (EHR) on at least two visits in the past year (defined as an average BP ≥ 140/90 mmHg) * Have been prescribed at least one anti-hypertensive medication and be non- adherent to their medications, defined as adherence \<80% in the preceding 12 months, as determined by prescription orders obtained from the clinic EHR.	* Being deemed unable to comply with the study protocol (either self-selected or by indicating during screening that s/he could not complete all requested tasks) * Participation in other hypertension-related clinical trials * Have significant psychiatric comorbidity or reports of substance abuse (as documented in the EHR) * Plan to discontinue care at their practice within the next 12 months

Inclusion Criteria

Exclusion Criteria

* Self-identify as Latino
* Be fluent in English or Spanish
* Be age 18 years or older
* Receiving care in a safety-net primary care practice
* Have uncontrolled HTN documented in the electronic health record (EHR) on at least two visits in the past year (defined as an average BP ≥ 140/90 mmHg)
* Have been prescribed at least one anti-hypertensive medication and be non- adherent to their medications, defined as adherence \<80% in the preceding 12 months, as determined by prescription orders obtained from the clinic EHR.

* Being deemed unable to comply with the study protocol (either self-selected or by indicating during screening that s/he could not complete all requested tasks)
* Participation in other hypertension-related clinical trials
* Have significant psychiatric comorbidity or reports of substance abuse (as documented in the EHR)
* Plan to discontinue care at their practice within the next 12 months

Contacts and Locations

Study Contact

Jocelyn Cruz, MPH

CONTACT

6465013474

Jocelyn.Acosta@nyulangone.org

Principal Investigator

Antoinette Schoenthaler, EdD

PRINCIPAL_INVESTIGATOR

NYUMC Langone

Study Locations (Sites)

NYUMC Langone

New York, New York, 10016

United States

Collaborators and Investigators

Sponsor: NYU Langone Health

Antoinette Schoenthaler, EdD, PRINCIPAL_INVESTIGATOR, NYUMC Langone

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2020-12-01

Study Completion Date2027-11-30

Study Record Updates

Study Start Date2020-12-01

Study Completion Date2027-11-30

Terms related to this study

Additional Relevant MeSH Terms

Hypertension